Incannex Healthcare Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
Incannex Healthcare Inc. (IXHL) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 3.65 thousand shares for the 9-month period ending 2026-03-31, per its 10-Q filed 2026-05-15.
Financial Statements › Shareholders' Equity › Shares Granted or Issued, Share-Based Payment Arrangement
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2026-05-15
- Incannex Healthcare Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-03-31 was -105.69K shares.
- Incannex Healthcare Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-12-31 was 0.00 shares.
- Incannex Healthcare Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-09-30 was 109.33K shares.
- Incannex Healthcare Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2024-06-30 was 49.00K shares.
- Incannex Healthcare Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2025 was 7.50K shares, a 98.12% decline from fiscal 2024.
- Incannex Healthcare Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2024 was 398.50K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month |
|---|---|---|---|---|
| 2026-03-31 | -105.69K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-15 | -105.69K shares derived: sum of 2 quarters · filed 2026-05-15 | 3.65K shares 10-Q · filed 2026-05-15 | |
| 2025-12-31 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-13 | 109.33K shares 10-Q · filed 2026-02-13 | ||
| 2025-09-30 | 109.33K shares 10-Q · filed 2025-11-14 | |||
| 2025-06-30 | 7.50K shares 10-K · filed 2025-09-29 | |||
| 2024-06-30 | 49.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-30 | 398.50K shares 10-K · filed 2024-09-30 | ||
| 2024-03-31 | 349.50K shares 10-Q · filed 2024-05-15 | |||
| 2023-12-31 | 349.50K shares 10-Q · filed 2024-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B |